For UK trials, the Chief Investigator will approach a potential sponsor (often through a formal registration process) who will assess the operational risk the trial poses before confirming sponsorship. For NHS sponsors, this is usually performed by the NHS R&D office of that organisation. Sponsorship will only be granted once any issues raised by the risk assessment have been addressed. The sponsorship letter should be retained in the Trial Master File.
The sponsor’s signature is required on both the application for ethical approval and for MHRA authorisation.
Other parties, including trial funders and host organisations conducting the trial will also require documented assurance that an organisation has accepted the role of sponsor and the obligations and responsibilities of this role.
- Research Governance Framework 2nd Edition (PDF, 36 KB)
- Research Governance Framework for Health and Social Care for Wales, 2nd edition 2009 (PDF, 617 KB)
- Research Governance Framework for Health and Community Care for Scotland (2nd Edition) (PDF, 244 KB)
- Research Governance Framework for Health and Social Care for Northern Ireland (PDF, 350 KB)